Health product recall

Biofire® Blood Culture Identification 2 (BCID2)

Last updated

Summary

Product
Biofire® Blood Culture Identification 2 (BCID2)
Issue
Medical devices - Performance
What to do

Contact Biomérieux for additional assistance or questions.

Audience
Healthcare

Affected products

Affected products

Lot or serial number

Model or catalogue number

Biofire® Blood Culture Identification 2 (Bcid2)

2278923
2086722
1611723
2025922
2502223
1785622
2146723
2500523
0798022
2067123

RFIT-ASY-0147

Issue

Biomérieux has identified an increased risk of false positive candida tropicalis results when the Biofire® BCID2 panel is used with the following BD BACTEC™ blood culture vials.

BD BACTEC™ Lytic Anaerobic Medium

BD BACTEC™ Peds Plus Medium 

BD BACTEC™ Plus Aerobic Medium 

BD BACTEC™ Plus Anaerobic Medium 

BD BACTEC™ Standard Aerobic Medium 

BD BACTEC™ Standard Anaerobic Medium 

 

Recall start date: February 6, 2024

Additional information

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Chemistry
Companies
Biofire Diagnostics, Llc.
515 Colorow Dr., Salt Lake City, Utah, United States, 84108
Published by
Health Canada
Audience
Healthcare
Recall class
Type II
Identification number
RA-75069

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe